HMGCL
protein-coding3-hydroxy-3-methylglutaryl-CoA lyase
Gene summary
The protein encoded by this gene belongs to the HMG-CoA lyase family. It is a mitochondrial enzyme that catalyzes the final step of leucine degradation and plays a key role in ketone body formation. Mutations in this gene are associated with HMG-CoA lyase deficiency. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: ClinGen
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009520
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic
Intervention: Biochemical
Rationale: Treatment to prevent and efficiently treat metabolic decompenstation can be beneficial; Avoidance of prolonged fasting and chronic low-fat, protein (including leucine)-restricted diet with carnitine supplementation can be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HMGCL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000191.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 146 | 1 | 153 | ||
| missense | 2 | 19 | 124 | 5 | 150 | |
| nonsense | 10 | 12 | 1 | 23 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 24 | 19 | 2 | 45 | ||
| splice donor/acceptor (+/-2bp) | 4 | 21 | 1 | 26 | ||
| Total | 40 | 72 | 135 | 151 | 1 | 399 |
Highest pathogenic variant AF is 0.00008735756
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000182.2 | 9 | MANE Select | |
| Ensembl | ENSP00000363614.3 | 9 | MANE Select | |
| RefSeq | NP_001159531.1 | 7 | Standard | |
| Ensembl | ENSP00000235958.4 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Butanoate metabolism - Homo sapiens (human)
- Peroxisome - Homo sapiens (human)
- Synthesis and degradation of ketone bodies - Homo sapiens (human)
- Valine, leucine and isoleucine degradation - Homo sapiens (human)
- 3-Methylglutaconic Aciduria Type I
Biological Process
- liver development
- leucine catabolic process
- protein targeting to peroxisome
- lipid metabolic process
- acyl-CoA metabolic process
Molecular Function
- fatty-acyl-CoA binding
- magnesium ion binding
- hydroxymethylglutaryl-CoA lyase activity
- signaling receptor binding
- manganese ion binding
Cellular Component
- mitochondrion
- mitochondrial matrix
- peroxisome
- peroxisomal matrix
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000374490
- Coding exons
- 9
- Length
- 36736
- Individuals with no LoFs
- 125699
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 49
- Defined
- 125748
- p
- 0.000195
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.460 | 157 | 174 | 0.902 | 0.00000900 | 2086 |
| Missense (PolyPhen) | 54 | 74.291 | 0.72687 | 903 | ||
| Synonymous | -0.128 | 67 | 65.7 | 1.02 | 0.00000362 | 672 |
| Loss of Function | 1.23 | 11 | 16.4 | 0.672 | 7.92e-7 | 198 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00046 | 0.00046 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.00039 | 0.00039 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Key enzyme in ketogenesis (ketone body formation). Terminal step in leucine catabolism. Ketone bodies (beta- hydroxybutyrate, acetoacetate and acetone) are essential as an alternative source of energy to glucose, as lipid precursors and as regulators of metabolism. {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860, ECO:0000269|PubMed:8566388}.;
Recessive Scores
- pRec
- 0.246
Intolerance Scores
- LoFtool
- 0.276
- RVIS EVS
- -0.6
- RVIS percentile EVS
- 17.75
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.997
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |